Zimmer Biomet Holdings Company Profile (NYSE:ZMH)

Analyst Ratings

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZMH) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $119.50 (5.23% upside)

Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZMH)
Show:
DateFirmActionRatingPrice TargetActions
1/7/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Royal Bank Of CanadaReiterated RatingOutperform$136.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Deutsche Bank AGReiterated RatingHold$107.00 -> $114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Zimmer Biomet Holdings (NYSE:ZMH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZMH)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Zimmer Biomet Holdings (NYSE:ZMH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Zimmer Biomet Holdings (NYSE:ZMH)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Zimmer Biomet Holdings (NYSE:ZMH)
DateHeadline
07/26/16 07:59 PMZimmer Biomet releases suite of solutions to assist in transition to value-based health care models
07/26/16 11:01 AMZimmer Biomet launches consulting service
07/26/16 11:01 AMZimmer Biomet Holdings Inc : half-yearly earnings release
07/26/16 05:30 AMZimmer Biomet Unveils Signature Solutions™ - [PR Newswire] - Signature Solutions had its genesis in the mid-1990s, when Zimmer Biomet launched its expert consulting services in response to the evolving global shift toward value-based healthcare. Since then, the Company has advised more than 450 hospitals and healthcare facilities worldwide on improving the value of their musculoskeletal programs by providing better care, lowering costs and increasing the number of patients treated. Signature Solutions will integrate Zimmer Biomet's established consulting platform, with a strategically curated suite of technologies and services, to form a one-of-a-kind offering that drives improvement across every aspect of the healthcare value creation equation. Initially, Zimmer Biomet will offer the comprehensive suite of solutions to musculoskeletal healthcare service lines at select, academic facilities in the U.S., with a broader release scheduled for 2017.
07/19/16 07:38 PMZimmer Biomet to acquire Medtech
07/19/16 08:23 AMZimmer Biomet to Buy French Surgical Robotics Company
07/14/16 07:41 PMFirst Manhattan Co Modifies Its Ownership in Zimmer Biomet Holdings, Inc. Co (ZBH)
07/14/16 11:03 AMLatest Zimmer Biomet Acquisition in The Books
07/14/16 11:03 AMZimmer Biomet closes on LDR
07/13/16 10:16 AMZIMMER BIOMET HOLDINGS, INC. : Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K)
06/27/16 07:11 PMZimmer Biomet Buys LDR Holding for $1 Billion
06/21/16 06:50 PMZIMMER BIOMET HOLDINGS INC : ex-dividend day
06/16/16 07:36 PMZimmer Biomet breached deferred prosecution deal, U.S. says
06/16/16 07:36 PMZimmer Biomet Holdings Announces Launch of Secondary Offering of Common Stock
06/16/16 12:08 PMThe Ins and Outs of Moat Investing -
06/11/16 07:39 PMThe Pres. Americas of Zimmer Biomet Holdings (NYSE: ZBH) is Selling Shares
06/10/16 10:34 AMZimmer Biomet to acquire spinal device company for $1B
06/09/16 10:36 AMZimmer Biomet Announces $1B Acquisition
06/08/16 08:03 PMZimmer-Biomet to make acquisition
06/08/16 08:03 PMZimmer Biomet Holdings (ZBH) to Acquire LDR Holding (LDRH) for ~$1B
06/07/16 07:46 PMZimmer Biomet to acquire LDR
06/07/16 07:46 PMZimmer Biomet to buy Broomfield-based LDR for $1 billion, adds spine devices
06/07/16 07:46 PMZimmer Biomet Backs FY16 View; Agrees To Buy LDR Holding In $1 Bln Cash Deal
06/07/16 07:46 PMZimmer Biomet to Buy LDR for $1 Billion, Adds Spine Devices
06/07/16 07:46 PMZimmer Biomet Acquires Medical Device Maker LDR Holding
06/07/16 07:46 PMZimmer Biomet to Buy Fellow Medical Device Maker LDR Holding
06/07/16 06:00 AMZimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business - [PR Newswire] - Founded in France in 2000, LDR designs and commercializes innovative technologies making surgical procedures easier to perform and providing improved clinical outcomes in the treatment of spine disorders. The addition of LDR will bolster Zimmer Biomet's presence in the global Spine market and provide the Company with an immediate and a leading position in the fast growing cervical disc replacement (CDR) and MIS segments. The combination is expected to meaningfully accelerate the growth of Zimmer Biomet's Spine business through the incremental revenues associated with entry into the cervical disc replacement market and cross-portfolio selling opportunities to both Zimmer Biomet and LDR customer bases. Zimmer Biomet also expects the transaction to accelerate the future growth of its overall business. With respect to 2016, the Company reiterates its previously provided revenue guidance, an increase of 2.0% to 3.0% as compared to adjusted pro forma full year 2015 on a constant currency basis. The Company will update its revenue guidance to reflect this transaction at or about the time of closing. Zimmer Biomet is also reiterating its 2016 adjusted diluted EPS guidance of $7.85 - $8.00. The transaction is expected to be neutral to adjusted diluted EPS in 2017 and accretive thereafter.
06/06/16 09:04 AMZimmer Biomet's Prognosis Is Promising -
06/02/16 02:59 PMZMH Hammerman Ltd. :ZMH-IL: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 -
05/27/16 07:04 AMHealthcare Stock Overview: Zimmer Biomet Holdings Inc (NYSE:ZBH) - In most recently trading session on 5/25/2016, Zimmer Biomet Holdings, Inc. Company shares were Reiterated by Barclays on April 29, 2016 to "Overweight", Firm has raised the Price Target to $ 135 from a previous price target of $130.Company shares were ...
05/26/16 01:55 PMZimmer Biomet Holdings Becomes #105 Most Shorted S&P 500 Component, Replacing F5 Networks - In our new rank based on the most recent short interest data, Zimmer Biomet Holdings Inc (NYSE:ZBH) has taken over the position of #105 most shorted S&P 500 component, from F5 Networks, Inc. (NASDAQ:FFIV) which is now in the #51 spot. The "days to cover ...
05/25/16 12:17 PMArgus Research Upgrades Rating On Zimmer Biomet Holdings, Inc. Co (ZBH) - Zimmer Biomet Holdings, Inc. Co (NYSE:ZBH). Equity analyst Nomura issued its first research report on the stock with an initial rating of “Buy” and price target of $123.00. On March 4, 2016 the stock rating was set at “Hold” in a report from Argus ...
05/24/16 12:44 PMZimmer Biomet: Strong Q1, Integration Synergy Continues - On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. ZBH – a major player in the musculoskeletal industry. The consolidated company formed post the merger of the legacy Zimmer Holdings and Biomet, recently reported better ...
05/24/16 12:44 PMZimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016 - WARSAW, Ind., May 23, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders ...
05/20/16 01:14 AMZMH Hammerman Ltd. :ZMH-IL: Earnings Analysis: 2015 By the Numbers : May 20, 2016 -
05/19/16 04:03 AMZMH Hammerman Ltd. :ZMH-IL: Earnings Analysis: 2015 By the Numbers : May 19, 2016 -
05/17/16 01:06 PMZimmer Biomet Closes on Acquisition - Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has completed the acquisition of an Arizona medical device maker. The company says the deal for Cayenne Medical Inc. boosts its sports medicine capabilities. Cayenne Medical designs, develops and markets ...
05/16/16 06:30 AMZimmer Biomet Completes Acquisition of Cayenne Medical - [PR Newswire] - WARSAW, Ind., May 16, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the completion of its previously announced acquisition ...
05/07/16 06:15 AMZimmer Biomet Holdings, Inc. Co (ZBH) Ownership Increased by Sumitomo Mitsui Trust Holdings, Inc. - Sumitomo Mitsui Trust Holdings, Inc. says it bought 12,447 shares during the last quarter increasing its holdings in Zimmer Biomet Holdings, Inc. Co by 2.4%. Its stake stood at $57,101,000 an increase of $3,503,000 as of quarter end. These firms have also ...
05/04/16 05:31 AMZimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2016 Health Care Conference - WARSAW, Ind., May 3, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (nyse and six:ZBH), a global leader in musculoskeletal healthcare, today announced that it will be presenting at the Bank of America Merrill Lynch 2016 Health Care Conference at the ...
05/03/16 06:12 AMZimmer Biomet Holdings, Inc. Co (ZBH) Investment Increased by American Century Companies Inc - American Century Companies Inc reports that it raised its investment in Zimmer Biomet Holdings, Inc. Co shares by 9.8% in its quarterly SEC filing. Its stake was valued at $347,669,000 an increase of $43,025,000 as of quarter end. Here are a few additional ...
05/01/16 06:18 AMZimmer Biomet Q1 Profit Declines - Zimmer Biomet Holdings Inc (ZBH) was Reiterated by Barclays to "Overweight" according to the research note released today. In Addition To, the Company utilized $415.5 million of cash to repurchase 4.2 million shares. According to TIPRANKS data, the stock ...
11/06/15 04:30 PMZimmer wins first U.S. trial over NexGen Flex knee devices -
10/29/15 12:45 PMZimmer Biomet (ZBH) Tops Q3 Earnings, Revenue Outlook Cut -
10/29/15 07:59 AMZimmer Biomet (ZBH) Beats on Q3 Earnings, Revenues in Line -
10/27/15 03:35 PMWill Zimmer Biomet (ZBH) Retain Its Earnings Streak in Q3? -
10/15/15 10:41 AM3 MedTech Stocks Poised to Trump Earnings in Q3 -
09/30/15 01:35 PMZimmer Biomet: Combined Synergy Strong, Currency Bothers -
08/28/15 01:30 PMZimmer Biomet: Will Merger Synergies Counter Currency Woes? -
08/12/15 01:45 PMZimmer Biomet Impresses in Q2, Poised for Combined Synergy -

Social

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ZMH
  • CUSIP:
Key Metrics:
  • Previous Close: $113.56
  • 50 Day Moving Average: $113.34
  • 200 Day Moving Average: $115.50
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $6.36 EPS
  • Next Year EPS Consensus Estimate: $6.92 EPS
Additional Links:
Zimmer Biomet Holdings (NYSE:ZMH) Chart for Friday, July, 29, 2016